ReShape Lifesciences Inc
NASDAQ:RSLS

Watchlist Manager
ReShape Lifesciences Inc Logo
ReShape Lifesciences Inc
NASDAQ:RSLS
Watchlist
Price: 3.92 USD 22.5%
Market Cap: 1.2B USD

Intrinsic Value

RSLS doesn't have a meaningful market cap.

The intrinsic value of one RSLS stock under the Base Case scenario is 8.57 USD. Compared to the current market price of 3.92 USD, ReShape Lifesciences Inc is Undervalued by 54%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

RSLS Intrinsic Value
8.57 USD
Undervaluation 54%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
ReShape Lifesciences Inc

What is Valuation History?
Ask AI Assistant
What other research platforms think about RSLS?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is RSLS valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for ReShape Lifesciences Inc.

Explain Valuation
Compare RSLS to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about RSLS?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
ReShape Lifesciences Inc

Current Assets 6.3m
Cash & Short-Term Investments 2.5m
Receivables 761k
Other Current Assets 3m
Non-Current Assets 188k
PP&E 133k
Other Non-Current Assets 55k
Current Liabilities 4.1m
Accounts Payable 1.7m
Accrued Liabilities 1.2m
Other Current Liabilities 1.3m
Non-Current Liabilities 1.1m
Other Non-Current Liabilities 1.1m
Efficiency

Free Cash Flow Analysis
ReShape Lifesciences Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
ReShape Lifesciences Inc

Revenue
7.2m USD
Cost of Revenue
-2.6m USD
Gross Profit
4.6m USD
Operating Expenses
-10.9m USD
Operating Income
-6.3m USD
Other Expenses
2.8m USD
Net Income
-3.5m USD
Fundamental Scores

RSLS Profitability Score
Profitability Due Diligence

ReShape Lifesciences Inc's profitability score is 21/100. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin
ROE is Increasing
Operating Margin is Increasing
Strong 3Y Average Gross Margin
21/100
Profitability
Score

ReShape Lifesciences Inc's profitability score is 21/100. The higher the profitability score, the more profitable the company is.

RSLS Solvency Score
Solvency Due Diligence

ReShape Lifesciences Inc's solvency score is 68/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Low D/E
Short-Term Solvency
Long-Term Solvency
68/100
Solvency
Score

ReShape Lifesciences Inc's solvency score is 68/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

RSLS Price Targets Summary
ReShape Lifesciences Inc

There are no price targets for RSLS.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

ReShape Lifesciences Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for RSLS is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

RSLS Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one RSLS stock?

The intrinsic value of one RSLS stock under the Base Case scenario is 8.57 USD.

Is RSLS stock undervalued or overvalued?

Compared to the current market price of 3.92 USD, ReShape Lifesciences Inc is Undervalued by 54%.

Back to Top